
Oncology remains at the forefront of the application of individualized or zzso approaches to cancer zzso This approach acknowledges cancer as a genetic disease, driven by zzso in zzso and tumor zzso with the strategy of using this information to guide therapy based on zzso capable of targeting specific zzso Recent advances suggest a changing landscape in how management decisions are approached for the patient with zzso cell lung zzso An expanding and functionally useful zzso of novel targeted agents and zzso to drive therapeutic choices is beginning to impact patient zzso This article reviews key advances, with commentary and perspective for the practicing zzso surgical zzso 

